SE
88
5
MAC
47
-3
ADP
74
-2
F
44
-2
MHK
43
-2
EQR
31
-2
WEC
65
2
IR
57
-4
VIX
60
11
HPQ
57
-3
PPL
69
2
SYF
65
-2
PSX
32
-3
R
68
-2
NEM
57
2
SIG
37
-3
NTRS
64
-5
M
34
-5
RL
79
-4
K
59
6
SE
88
5
MAC
47
-3
ADP
74
-2
F
44
-2
MHK
43
-2
EQR
31
-2
WEC
65
2
IR
57
-4
VIX
60
11
HPQ
57
-3
PPL
69
2
SYF
65
-2
PSX
32
-3
R
68
-2
NEM
57
2
SIG
37
-3
NTRS
64
-5
M
34
-5
RL
79
-4
K
59
6
Financhill
Back

Allegiant Travel Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
42

ALGT
Allegiant Travel

Last Price:
$52.31
Seasonality Move:
-0.36%
Sell
34

APLS
Apellis Pharmaceuticals

Last Price:
$17.45
Seasonality Move:
2.29%
Sell
42
Allegiant Travel (ALGT) is a Sell

Is Allegiant Travel a Buy, Sell or Hold?

  • The current Allegiant Travel [ALGT] share price is $52.34. The Score for ALGT is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • ALGT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $17.44. The Score for APLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ALGT Stock Price Chart

What is Allegiant Travel's stock price today?

  • The Allegiant Travel share price today is $52.34
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALGT is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $17.44
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight buying pressure.

ALGT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.88 Buy
Relative Strength Index (14 RSI): 49.41 Sell
Chaikin Money Flow: 177446 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46 - 55.78) Buy
Bollinger Bands (100): (47.72 - 90.98) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.67 Sell
Relative Strength Index (14 RSI): 42.89 Sell
Chaikin Money Flow: 20534 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.01 - 18.99) Sell
Bollinger Bands (100): (19.23 - 29.65) Sell

ALGT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.38 Sell
20-day SMA: 52.54 Sell
50-day SMA: 50.69 Buy
200-day SMA: 64.54 Sell
8-day EMA: 53.66 Sell
20-day EMA: 52.78 Sell
50-day EMA: 55.1 Sell
200-day EMA: 64.38 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.42 Buy
20-day SMA: 18.11 Sell
50-day SMA: 19.97 Sell
200-day SMA: 28.53 Sell
8-day EMA: 17.62 Sell
20-day EMA: 18.04 Sell
50-day EMA: 20.09 Sell
200-day EMA: 28.66 Sell

Allegiant Travel Earnings Growth & ALGT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.77 per share, an increase next quarter of $3.01 per share, an increase this year of $0.98 per share, and an increase next year of $3.28 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.19 per share, a decrease this year of $0.19 per share, and an increase next year of $1.21 per share.

Allegiant Travel Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):